medigraphic.com

2005, Número 1

<< Anterior Siguiente >>

Rev Hosp Jua Mex 2005; 72 (1)


Tratamiento quirúrgico del cáncer de páncreas

Pérez GR

Idioma: Español
Referencias bibliográficas: 29
Paginas: 28-32
Archivo PDF: 46.35 Kb.


RESUMEN

El cáncer de páncreas es una de las neoplasias malignas más agresivas y la cuarta causa de mortalidad en los EUA. Afortunadamente, en México es poco frecuente. Es una de las neoplasias con mayor grado de mortalidad, desde que a pesar de los tratamientos actuales, la mayoría de los pacientes mueren a causa de esta enfermedad. Actualmente, la tomografía computada convencional y/o helicoidal, colangiografía endoscópica y el ultrasonido endoscópico ofrecen una mejor opción para el diagnóstico y conocimiento del estadio clínico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Levy P. Does laparoscopy still improve the accuracy of preoperative resectability staging of pancreatic head adenocarcinoma at the era of spiral CT and endoscopy ultrasonography? Gastroenterol 2001; 120: 4085.

  2. Jacobson ED, Levine JL. Clinical G1 phisiology for the exam taker. Philadelphia: WB Saunders, 1994; 45-56.

  3. Gorelik FS, Jamieson JD. The pancreatic acinar cell; structure-function relationships. Johnson LR (ed.) Phisiology of the gastrointesatinal tract. 3a. ed. Vol. 2. New York Raven 1994: 1353-76.

  4. Whipple AO, Parson WB, Mullens CR. Treatment of carcinoma of the Ampulla the Vater. Ann Surg 1935; 102: 763-79.

  5. Traverso LW, Longmire WP Jr. Preservation of the pylorus in pancreatic duodenectomy. Surg Gynecol Obstet 1978; 146: 959-62.

  6. Grace Pa, Pitt HA, Topkins RK, et al. Decrease morbidity and mortality after pancreato duodenectomy. AMJ Surg 1986; 151: 141-9.

  7. Crist DW, Sitz Mann JV, Cameron JL. Improved hospital morbidity, mortality and survival after the Whipple procedure. Ann Surg 1987; 206: 358-65.

  8. Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and forty five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993; 217: 430-8.

  9. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 1990; 211: 447-58.

  10. Gordan TA, Burleyson GP, Tielsch, et al. The effects of regionalization on cost and outcome for one high-risk surgical procedure. Ann Surg 1995; 221: 43-9.

  11. Reber HA, Aschley SW, McFaaden D. Curative treatment for pancreatic neoplas MS: Radical Resection. Surg Clin North Am 1995; 75: 905-12.

  12. Sasson AR, Hoffman JP, et al. In block resection for locally advanced cancer of the pancreas: Is it Worth while? Gastroenterology 2001; 120: 565.

  13. Shapiro TM. Adenocarcinoma of the pancreas: A statystical analysis of byliary bypass vs Whipple resection in good risk patients. Ann Surg 1975; 182: 715-21.

  14. Forrest J, Longmire WP Jr. Carcinoma of the pancreas and periampulary region: study of 279 patients. Ann Surg 1979; 189: 129-38.

  15. Chmiel JSJ. Pancreatic cancer in Illinois. A report by 8 Hospitals on 2,401 patients diagnosed 1978-84. Am Surg 1991; 7(8): 490-5.

  16. Geer RJ, Brennan MF. Pronostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165: 68-73.

  17. Piza Bernal R, Miranda Lluke, Ochoa Martínez M, Días Campos FJ. Pancreatoduodenectomía con conservación de píloro. Rev Gastroenterol Mex 1988; 53: 119-23.

  18. Grace PA, Pitt HA, Longmire WP Jr. Pancreatoduodenectomy with Pylorus preservation for adenocarcinoma of the head of the pancreas. Br J Surg 1986; 73: 647-50.

  19. Tran KT, Smeenk HG, Casper HJ,Van Eijck, et al. Pylorous preserving pancreaticoduodenectomy versus standard Whipple procedure: A Prospective, Randomized, multicenter analysis of 170 patients. With pancreatic and periampullary tumors. Ann Surg 2004; 240: 738-45.

  20. Crist DW, Sitz Mann JV, Cameron JL. Improved Hospital morbidity, mortality and survival after the Whipple procedure. Ann Surg 1987; 206: 358-65.

  21. Lillemoe KA, Sauter PK, Pittha, Yeo CJ, Cameron JL. Current status of surgical palliation of preriampullary carcinoma. Surg Gyneco Obstet 1993; 176: 1-10.

  22. Douglas HO, Nava HR, Panahon A. Further evidence of effective adjuvant combined radiation and chemoterapy following curative resection of pancreatic cancer. Cancer 1987; 57: 2006.

  23. Kaiserma, Ellenbere SS. Pancreatic cancer: adyuvant combined radiation and chemoterapy following curative resection. Arch Surg 1985; 120: 899.

  24. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-10.

  25. Pérez Castro J, Amezcua G, Siglerl, Blanco Benavides R. Tratamiento quirúrgico paliativo del carcinoma de páncreas. Rev Med IMSS 1989; 27: 267-72.

  26. Lillemoe DK, Barnes SA. Surgical palliation of unresectable pancreatic carcinoma. Surg Clin North Am 1995; 75: 9563-8.

  27. Mosdell LEM, Kessler C, Morris DM. Unresectable pancreatic cancer: what is the optimal procedure? South Med J 1991; 84: 571-4.

  28. Lillemore KD, Cameron JL, et al. Is prophilactic gastroyeyunostomy indicated for unresectable periampulary cancer? A prospective randomized trial. Ann Surg 1999; 230: 322-30.

  29. Brooks AD. The role of prophylactic gastric bypass in advanced pancreatic cancer. Gastroenterology 2001; 120: 2454.




2020     |     www.medigraphic.com